Sponsorship verdict
No sponsorship evidence yet
No government record and no wording either way. Not a refusal: ask the recruiter.
-
?
No government sponsor record hereThis employer posted directly and does not match a government sponsor register.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
Before you apply
Sponsorship unknown
No register record and no sponsorship wording in the posting. Worth asking the employer before investing significant time.
These come from the posting’s own wording. Read the original listing to confirm. See better-fit alternatives →
About the role
Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need.
As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the biopharmaceutical company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more about our neuromuscular franchise at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.
Summary of Position:
The Patient Advocacy & Corporate Communications Lead, EMEA will be responsible for developing and executing integrated patient advocacy and communications strategies that advance the company's mission, strengthen stakeholder trust, and support business objectives across the region, starting with Spinal Muscular Atrophy (SMA) and including facioscapulohumeral dystrophy (FSHD) in line with clinical development milestones.
This role will serve as the primary EMEA lead for patient advocacy engagement while also driving corporate and product communications, executive visibility, disease awareness initiatives, and internal communications. The successful candidate will engage the SMA community (and communities for future disease states) to establish and solidify trust and act as a connector to patient and advocate perspectives to drive Scholar Rock’s patient first values. They will act as a trusted strategic advisor to regional leadership and work cross-functionally with Medical Affairs, Global patient advocacy and communications, Market Access, Clinical Development, Regulatory, and Commercial Teams, supported by global and regional agency partners.
The ideal candidate combines deep understanding of the rare disease community with exceptional communications and stakeholder management capabilities and the ability to thrive in a fast-paced, entrepreneurial biotech environment.
Position Responsibilities
Patient Advocacy Leadership
Develop and Execute Advocacy Strategy
• Contribute to the development and implementation of a comprehensive EMEA patient advocacy strategy aligned with corporate and regional objectives, starting in the SMA community and building the FSHD relationships.
• Ensure patient and caregiver perspectives are appropriately incorporated throughout the product lifecycle, from clinical development through commercialization.
• Identify emerging opportunities and risks within the advocacy and policy environment and provide strategic recommendations to leadership.
• Foster a patient-centric culture throughout the organization.
Build Meaningful Community Partnerships
• Establish and maintain authentic, trusted relationships with regional and national patient organizations, advocacy leaders, caregivers, and community stakeholders.
• Serve as the primary company representative to patient advocacy organizations associated with direct-to-market counties throughout EMEA
• Support development of and monitor execution against a patient advocacy group engagement playbook for partner market countries ensuring advocate engagement follows Scholar Rock standards
• Identify, deliver, and participate in collaborative initiatives that support disease awareness, education, research, access, and policy priorities.
• Build long-term collaboration based on transparency, trus
View original listing ↗